Your browser doesn't support javascript.
loading
A prospective multi-faceted interventional study of blood bank technologist screening of red blood cell transfusion orders: The START study.
Kron, Amie T; Collins, Allison; Cserti-Gazdewich, Christine; Pendergrast, Jacob; Webert, Kathryn; Lieberman, Lani; Zeller, Michelle P; Harding, Sheila R; Nahirniak, Susan; Prokopchuk-Gauk, Oksana; Lin, Yulia; Mendez, Brent; Armali, Chantal; Lee, Christina; Watson, Danielle; Arnott, Dena; Xun, Fengju; Blain, Heather; Panchuk, Heather; Hughes, Hertha; Chorneyko, Kathy; Angers, Michael; Pilutti, Nicole; Lett, Ryan; Dowsley, Shauna; Ruijs, Theodora; Cupido, Tracy; Kichinko, Tracy; Thompson, Troy; Afshar-Ghotli, Zohreh; Callum, Jeannie.
Afiliación
  • Kron AT; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Collins A; Ontario Regional Blood Coordinating Network (ORBCoN), Toronto, Ontario, Canada.
  • Cserti-Gazdewich C; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Pendergrast J; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
  • Webert K; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Lieberman L; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
  • Zeller MP; Canadian Blood Services, Ottawa, Ontario, Canada.
  • Harding SR; Department of Molecular Medicine and Pathology, McMaster University, Hamilton, Ontario, Canada.
  • Nahirniak S; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Prokopchuk-Gauk O; Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
  • Lin Y; Canadian Blood Services, Ottawa, Ontario, Canada.
  • Mendez B; Department of Medicine, McMaster Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada.
  • Armali C; Department of Laboratory Medicine and Pathology, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada.
  • Lee C; Department of Laboratory Medicine and Pathology, Alberta Precision Laboratories, Grande Prairie, Alberta, Canada.
  • Watson D; Department of Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
  • Arnott D; Department of Laboratory Medicine and Pathology, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada.
  • Xun F; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Blain H; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Panchuk H; Department of Laboratory Medicine and Pathology, Alberta Precision Laboratories, Grande Prairie, Alberta, Canada.
  • Hughes H; Department of Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
  • Chorneyko K; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Angers M; Department of Laboratory Medicine and Genetics Program, Trillium Health Partners, Mississauga, Ontario, Canada.
  • Pilutti N; Department of Transfusion Medicine, Laboratory Services, Grey Bruce Health Services, Owen Sound, Ontario, Canada.
  • Lett R; Department of Laboratory Medicine and Pathology, Saskatchewan Health Authority, Regina, Saskatchewan, Canada.
  • Dowsley S; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Ruijs T; Human Biology Program, Faculty of Arts and Science, University of Toronto, Toronto, Ontario, Canada.
  • Cupido T; Department of Laboratory Medicine and Pathology, Alberta Precision Laboratories, Grande Prairie, Alberta, Canada.
  • Kichinko T; Department of Laboratory Medicine and Pathology, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada.
  • Thompson T; Department of Laboratory Medicine, Quinte Healthcare Corporation, Belleville, Ontario, Canada.
  • Afshar-Ghotli Z; Department of Laboratory Services, Brant Community Healthcare System, Brantford, Ontario, Canada.
  • Callum J; Laboratory Medicine Program, Lakeridge Health, Ajax, Ontario, Canada.
Transfusion ; 61(2): 410-422, 2021 02.
Article en En | MEDLINE | ID: mdl-33423316
ABSTRACT

BACKGROUND:

Transfusion of red blood cells (RBC) is a common procedure, which when prescribed inappropriately can result in adverse patient outcomes. This study sought to determine the impact of a multi-faceted intervention on unnecessary RBC transfusions at hospitals with a baseline appropriateness below 90%. STUDY DESIGN AND

METHODS:

A prospective medical chart audit of RBC transfusions was conducted across 15 hospitals. For each site, 10 RBCs per month transfused to inpatients were audited for a 5-month pre- and 10-month post-intervention period, with each transfusion adjudicated for appropriateness based on pre-set criteria. Hospitals with appropriateness rates below 90% underwent a 3-month intervention which included adoption of standardized RBC guidelines, staff education, and prospective transfusion order screening by blood bank technologists. Proportions of RBC transfusions adjudicated as appropriate and the total number of RBC units transfused per month in the pre- and post-intervention period were examined.

RESULTS:

Over the 15-month audit period, at the 13 hospital sites with a baseline appropriateness below 90%, 1950 patients were audited of which 81.2% were adjudicated as appropriate. Proportions of appropriateness and single-unit orders increased from 73.5% to 85% and 46.2% to 68.2%, respectively from pre- to post-intervention (P < .0001). Pre- and post-transfusion hemoglobin levels and the total number of RBCs transfused decreased from baseline (P < .05). The median pre-transfusion hemoglobin decreased from a baseline of 72.0 g/L to 69.0 g/L in the post-intervention period (P < .0001). RBC transfusions per acute inpatient days decreased significantly in intervention hospitals, but not in control hospitals (P < .001). The intervention had no impact on patient length of stay, need for intensive care support, or in-hospital mortality.

CONCLUSION:

This multifaceted intervention demonstrated a marked improvement in RBC transfusion appropriateness and reduced overall RBC utilization without impacts on patient safety.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Bancos de Sangre / Personal de Laboratorio Clínico / Transfusión de Eritrocitos / Procedimientos Innecesarios / Prescripciones / Prescripción Inadecuada / Auditoría Médica Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Screening_studies Límite: Adolescent / Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Transfusion Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Bancos de Sangre / Personal de Laboratorio Clínico / Transfusión de Eritrocitos / Procedimientos Innecesarios / Prescripciones / Prescripción Inadecuada / Auditoría Médica Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Screening_studies Límite: Adolescent / Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Transfusion Año: 2021 Tipo del documento: Article País de afiliación: Canadá